Final Program Introduction of CVRF
| Date | Time | Place | Session / Title | Role |
| April 29 | 3:30 PM - 4:30 PM | Room 105, Level 1 | ACC-i2 @ TCTAP 2018 | Chair |
| April 29 | 3:45 PM - 4:00 PM | Room 105, Level 1 | ACC-i2 @ TCTAP 2018 Interventional Pharmacology Year-In-Review |
Lecturer |
| April 30 | 7:00 AM - 8:00 AM | Room 105, Level 1 | Antithrombotic Therapy | Panelist |
| April 30 | 7:42 AM - 7:54 AM | Room 105, Level 1 | Antithrombotic Therapy Aspirin Plus NOAC Will Be the Standard of Care. |
Lecturer |
| April 30 | 11:15 AM - 12:30 PM | Coronary Theater, Level 1 | TCT @ TCTAP 2018 | Panelist |
| April 30 | 12:15 PM - 12:22 PM | Coronary Theater, Level 1 | TCT @ TCTAP 2018 HARMONEE: A Randomized Trial of a Bioabsorbable Polymer-based DES with a Luminal CD34+ Antibody Coating Versus a Durable Polymer-based DES in Patients with Coronary Artery Disease |
Lecturer |
| April 30 | 3:30 PM - 5:00 PM | Coronary Theater, Level 1 | Live Case & Lecture Session II | Moderator |
| April 30 | 4:30 PM - 4:40 PM | Coronary Theater, Level 1 | Live Case & Lecture Session II Optimal Balancing Ischemic and Bleeding Risks in Contemporary PCI Practice: TWILIGHT, GLOBAL-LEADER and More... |
Lecturer |
